| Follow Us: Facebook Twitter


(313) 872-6400

(313) 872-6400
5861 John C. Lodge Freeway
Detroit, Michigan 48202

Ash Stevens

"During the past 50 years, Ash Stevens has grown to become one of Southeast Michigan's largest biotechnology companies and a pioneer in producing the ingredients found in several cancer-treating drugs," Ficano told an audience of elected officials, company employees, and several of Southeast Michigan's most influential voices in the life sciences, including Dr. Roger Newton, co-founder of the drug Lipitor and CEO of Esperion Therapeutics, and Dr. Stephen Rapundalo, President and CEO of MichBio, Michigan's largest biosciences trade association.

"Today we thank Ash Stevens, not only for its continued investment in Wayne County, but for decades of research that have brought scientific advancements that have truly elevated the quality of life for people around the world," continued Ficano.

Ash Stevens, the first business to spin off from Wayne State's chemistry department in 1962, is a contract pharmaceutical manufacturing company that specializes in the manufacture of active pharmaceutical ingredients (APIs) for novel cancer drugs and other therapeutic agents in development. It shares a longstanding and successful relationship with the National Cancer Institute, and has recently received Food and Drug Administration manufacturing approvals for several innovator drugs, including the APIs in Velcade, Vidaza, and Clolar, all three fast track approvals.

"For nearly 50 years we have been building a strong reputation to be a trusted partner in the life science industry this expansion is possible thanks to our commitment to quality, delivery and client service as well as the forward-looking support of the local and state government," said Dr. Stephen Munk, CEO, Ash Stevens. "We considered locations in other states that were closer to our customers, but we've always wanted to stay in Michigan and now we are committed to expanding our workforce and infrastructure in our home community and state."

Ash Stevens' expansion will increase production by 50 to 80% and will add 60 jobs at the Riverview facility. The first phase of the expansion project involves the construction of a 10,000 sq. ft., state-of-the-art GMP storage and materials handling facility to accommodate the company's current and projected increase in business. Other phases of construction include a new 2,250-gallon reactor bay with 500-gallon, 750-gallon and 1,000-gallon vessels for the large scale

Ash Stevens is also consolidating its Detroit laboratories to a single site at the Riverview location within the next three to seven years.

Todd Fenton is a Senior Executive Project Manager with Wayne County EDGE

Related Content

Signup for Email Alerts